ResearcherNebraska Medical CenterNo recent work listed
Saber Amin
Matched on ORCID iD 0000-0002-8060-9144; OpenAlex author ID A5026901540. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 4 papers · 2021: none · 2022: 1 paper
Papers 5
- Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer. First author DOI 10.2217/fon-2021-0986↗
- The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor. Co-author DOI 10.1016/j.ctro.2020.06.003↗
- The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis. Co-author DOI 10.1186/s12885-020-07016-8↗
- The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective anal… Co-author DOI 10.1186/s13014-020-01569-5↗
- The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National… Co-author DOI 10.3389/fonc.2020.01518↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chi H. Lin · 5 shared papers, 2020–2022 · strength 0.88
- Paper Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer. DOI 10.2217/fon-2021-0986↗
- Paper The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective ana… DOI 10.1186/s12885-020-07016-8↗
- Paper The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: … DOI 10.3389/fonc.2020.01518↗
- Jane L. Meza · 4 shared papers, 2020 · strength 0.62
- Paper The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective ana… DOI 10.1186/s12885-020-07016-8↗
- Paper The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: … DOI 10.3389/fonc.2020.01518↗
- Paper The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery… DOI 10.1016/j.ctro.2020.06.003↗
- Michael J. Baine · 4 shared papers, 2020 · strength 0.62
- Paper The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective ana… DOI 10.1186/s12885-020-07016-8↗
- Paper The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: … DOI 10.3389/fonc.2020.01518↗
- Paper The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery… DOI 10.1016/j.ctro.2020.06.003↗
- Josiah McAllister · 1 shared paper, 2022 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.